If it's not a shrine, it's them immortalizing the label or logo as body tattoos ... helping bring in multinational giants like Cadbury, Boehringer Ingelheim and Samsung before heading up marketing ...

today announced that Boehringer Ingelheim is the latest global top 20 biopharma company to commit to moving to Veeva Vault ...

More than 530 million people worldwide living with diabetes are at risk for developing diabetic retinal disease (DRD), the leading cause of ...

today announced that Boehringer Ingelheim is the latest global top 20 biopharma company to commit to moving to Veeva Vault CRM. "We are excited to bring our innovative research to patients around the ...

The $66 million project is part of the company's obligation made to the state after it moved here to invest a total of $120 ...

Luckily, my “manager” was played by a British-accented actor and my new ailment was also fictional ... at Ridgefield biopharma firm Boehringer Ingelheim have taken part in the same program ...

No. 49 / 2024Zealand Pharma Announces Financial Results for the First Nine Months of 2024Continued strong progress across ...

Boehringer Ingelheim’s weight-loss drug candidate survodutide could also be effective for liver disease metabolic dysfunction-associated steatohepatitis (MASH), if the results of a mid-stage ...

With a capital investment of $66.1 million and 63 new jobs created ... U.S. Animal Health Country Managing Director at Boehringer Ingelheim. "Each year, we invest nearly 12 percent of our sales ...

Grand Opening of State-of-the-Art Research and Development Facility "Our new research and development ... Health Country Managing Director at Boehringer Ingelheim. "Each year, we invest nearly ...